QUALITY CONTROL LABORATORY
A test report for every released lot with recorded results: HPLC purity, measured mass against label claim, identity, USP <232> elemental impurities and USP <85> endotoxin. Scan a report's QR code, or enter its verification key at Verify.
Values are reproduced from each lot's recorded laboratory results; only tests that were performed appear on a report. Lots whose results are still pending are not listed. Kit reconstitution diluent and lab accessories are not assayed. For laboratory research use only — not for human consumption.
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.38 mg (103.8%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.40% | 99.58% | PASS |
| Identity (ESI-MS) | 4,731.3 Da ± 1.0 | 4,731.4 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 20 mg | 20.44 mg (102.2%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.40% | 99.62% | PASS |
| Identity (ESI-MS) | 4,731.3 Da ± 1.0 | 4,731.4 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.34 mg (103.4%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.30% | 99.49% | PASS |
| Identity (ESI-MS) | 4,813.5 Da ± 1.0 | 4,813.5 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.04 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 30 mg | 30.62 mg (102.1%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.30% | 99.55% | PASS |
| Identity (ESI-MS) | 4,813.5 Da ± 1.0 | 4,813.5 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 5 mg | 5.21 mg (104.2%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.30% | 99.64% | PASS |
| Identity (ESI-MS) | 4,113.6 Da ± 1.0 | 4,113.7 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 5 mg | 5.18 mg (103.6%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.20% | 99.41% | PASS |
| Identity (ESI-MS) | 4,409.0 Da ± 1.0 | 4,409.2 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.04 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 50 mg | 50.85 mg (101.7%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.50% | 99.72% | PASS |
| Identity (ESI-MS) | 286.1 Da ± 1.0 | 286.2 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.02 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 5 mg | 5.19 mg (103.8%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.20% | 99.38% | PASS |
| Identity (ESI-MS) | 1,815.1 Da ± 1.0 | 1,815.2 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.04 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.29 mg (102.9%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.20% | 99.46% | PASS |
| Identity (ESI-MS) | 2,174.6 Da ± 1.0 | 2,174.7 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.42 mg (104.2%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.50% | 99.74% | PASS |
| Identity (ESI-MS) | 1,419.5 Da ± 1.0 | 1,419.6 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.02 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.36 mg (103.6%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.30% | 99.52% | PASS |
| Identity (ESI-MS) | 4,963.4 Da ± 1.0 | 4,963.6 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 16 mg | 16.41 mg (102.6%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.30% | 99.48% | PASS |
| Identity (ESI-MS) | 1,257.3 Da ± 1.0 | 1,257.4 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.31 mg (103.1%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.50% | 99.68% | PASS |
| Identity (ESI-MS) | 354.5 Da ± 1.0 | 354.5 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.02 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.35 mg (103.5%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.20% | 99.44% | PASS |
| Identity (ESI-MS) | 5,135.8 Da ± 1.0 | 5,135.9 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 5 mg | 5.22 mg (104.4%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.30% | 99.56% | PASS |
| Identity (ESI-MS) | 3,367.9 Da ± 1.0 | 3,368.0 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.39 mg (103.9%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.50% | 99.69% | PASS |
| Identity (ESI-MS) | 711.9 Da ± 1.0 | 711.9 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.02 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 1 mg | 1.06 mg (106.0%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.10% | 99.34% | PASS |
| Identity (ESI-MS) | 9,117.5 Da ± 1.0 | 9,117.7 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.04 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.28 mg (102.8%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.30% | 99.51% | PASS |
| Identity (ESI-MS) | 3,357.9 Da ± 1.0 | 3,358.0 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.45 mg (104.5%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.40% | 99.61% | PASS |
| Identity (ESI-MS) | 6,383.0 Da ± 1.0 | 6,383.1 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.38 mg (103.8%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.40% | 99.57% | PASS |
| Identity (ESI-MS) | 4,079.8 Da ± 1.0 | 4,079.9 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.33 mg (103.3%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.30% | 99.48% | PASS |
| Identity (ESI-MS) | 8,522.6 Da ± 1.0 | 8,522.7 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 50 mg | 51.12 mg (102.2%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.50% | 99.76% | PASS |
| Identity (ESI-MS) | 403.9 Da ± 1.0 | 404.0 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.02 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 100 mg | 101.40 mg (101.4%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.40% | 99.63% | PASS |
| Identity (ESI-MS) | 418.0 Da ± 1.0 | 418.1 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.32 mg (103.2%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.40% | 99.59% | PASS |
| Identity (ESI-MS) | 1,024.2 Da ± 1.0 | 1,024.3 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 500 mg | 506.40 mg (101.3%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.60% | 99.81% | PASS |
| Identity (ESI-MS) | 663.4 Da ± 1.0 | 663.5 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.02 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.37 mg (103.7%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.50% | 99.67% | PASS |
| Identity (ESI-MS) | 390.4 Da ± 1.0 | 390.4 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.02 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 600 mg | 608.20 mg (101.4%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.60% | 99.79% | PASS |
| Identity (ESI-MS) | 307.3 Da ± 1.0 | 307.4 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.02 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 30 mg | 30.58 mg (101.9%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.40% | 99.62% | PASS |
| Identity (ESI-MS) | 813.9 Da ± 1.0 | 814.0 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.34 mg (103.4%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.40% | 99.58% | PASS |
| Identity (ESI-MS) | 751.9 Da ± 1.0 | 752.0 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.29 mg (102.9%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.30% | 99.47% | PASS |
| Identity (ESI-MS) | 1,034.2 Da ± 1.0 | 1,034.3 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.03 EU/mg | PASS |
Schematic trace drawn from the reported area-% purity; the instrument chromatogram is in the laboratory's original report.
| Test | Specification | Result | Status |
|---|---|---|---|
| Active compound assay | 10 mg | 10.41 mg (104.1%) | PASS |
| RP-HPLC purity (220 nm) | ≥ 99.40% | 99.65% | PASS |
| Identity (ESI-MS) | 1,025.2 Da ± 1.0 | 1,025.3 Da | PASS |
| Endotoxin (USP <85> LAL) | < 0.50 EU/mg | 0.02 EU/mg | PASS |